Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia

NCT01330667 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01330667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01330667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Early Limited Formula on Total Serum Bilirubin Among Newborns With Hyperbilirubinemia
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Withdrawn
Start date
July 31, 2015
Completion date
June 30, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperbilirubinemia, neonatal